This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (January 2007)

CNBC-TV18 is a business news channel broadcast in India based in Mumbai. The channel was launched on December 7, 1999. It was the first business news channel launched in India and still leads that genre. The channel has been an integral part of the Indian economic story, spearheading and mirroring India's enterprising times.

The channel's benchmark coverage extends from corporate news, financial markets coverage, and expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India’s most able business audience consumes CNBC-TV18 for their information and investing needs. This audience is highly diversified, at one level comprising key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, high-net-worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise. CNBC-TV18 is available in over 35 million households in India.

Programming[link]

Current on-air staff[link]

CNBC-TV18's Key Milestones[link]

• CNBC-TV18 was the First 24 hr business news channel in the country – Launched in 1999 as CNBC India and was later re-christened CNBC-TV18
• CNBC-TV18 has maintained a dominant position in market share, despite the emergence of competition in recent years. The channel has consistently delivered more than 50% market share
• The channel has won Best Business News Channel awards at all major recognized industry events, apart from numerous other accolades across national & international platforms. These include the acclaimed Indian Telly Awards, Indian Television Academy & News Television Awards
• The Indian marketing & media decision makers have rated CNBC-TV18 India’s No.1 TV Brand in a market that has over 400 TV brands competing for eyeballs (Pitch Brandometer Survey 2009)
• CNBC-TV18 runs India's largest platform for recognizing & rewarding accomplishments of Indian SME's - The Emerging India Awards. The Awards are listed in the Limca book of records as they received the highest number of entries for any business awards in the country till date.
• CNBC-TV18 runs India’s most respected and sought after awards for recognizing business & entrepreneurial achievement, the CNBC-TV18 India Business Leader Awards (IBLA). The IBLA re-inforces the prestige of CNBC Asia’s “Asia Business Leader Awards” (ABLA) in the country.
• CNBC-TV18 was the first channel to deliver beam live INTERNATIONAL business news programming into the country and show live opening of global exchanges, across the world
• CNBC-TV18’s Storyboard is the longest-running show focused on Advertising and Marketing
• CNBC-TV18 was the 1st channel to have a dedicated show on corporate law in India, The Firm
• CNBC-TV18’s Young Turks is one of India’s first dedicated & longest-running shows focusing on young entrepreneurs
• CNBC-TV18 Launched CNBC TV18 Prime HD. India's First Business news channel in HD.

CNBC-TV18 taglines[link]

• "Profit From It" (2000—2008)
• "The World Leader in Business News" (2004—2008)
• "First in Business Worldwide" (2008—present)

Publishing[link]

CNBC-TV18 also publishes business and investing books and DVDs through Network18's division BestSellers18. The collection of books and DVDs range a broad spectrum of topics right from economics, stock markets, finance, entrepreneurship, management, business empowerment and philosophy.

Graphics[link]

2008-01-07 revamp[link]

Started 7 January 2008, CNBC-TV18 had patterned its graphics, some parts of the lower-thirds, title cards to the main network (CNBC) in the United States and unlike the regional channel, its graphics are in 3d. Although it has retained the old ticker (similar to the CNBC US 2002 graphics) and stock bar (similar to the CNBC US 2003 graphics), which is above the channel DOG, it has moved it to the top of the screen during CNBC Asia, NBC and CNBC US programmes.

2010-03-29 revamp[link]

Started March 29, 2010, CNBC-TV18 made another revamp, to make some of its lower-thirds look like CNBC US.

CNBC-TV18 HD[link]

This section requires expansion.

CNBC-TV18 is available in HD on DishTV and hathway.

See also[link]

• CNBC

Competitors[link]

• ET Now
• NDTV Profit
• Zee Business
• CNBC Awaaz
• CNN-IBN
• Bloomberg UTV
• NDTV 24x7
• Times Now
• Headlines Today
• NewsX

External links[link]

• CNBC-TV18
  • cnbctv18's channel on YouTube
  • CNBC-TV18 on Twitter
  • CNBC-TV18 on Facebook
• Network 18 Official website
• In.com - Latest Online venture from Network 18 Group

v t e NBCUniversal LLC A joint venture of Comcast (51%) and General Electric (49%) Company Officials Board of Directors Stephen B. Burke (CEO) · Brian Roberts · Michael Angelakis · Jeffrey Immelt · Keith Sherin Senior Corporate Executives Stephen B. Burke (CEO) · Matt Bond · Lynn Calpeter (CFO) · Steve Capus · Richard Cotton · Dick Ebersol · Patricia Fili-Krushel · Robert Greenblatt · Bonnie Hammer · Ted Harbert · Mark Hoffman · Paula Madison · Ron Meyer · Adam Miller · Jeff Shell · Page Thompson · Lauren Zalaznick Universal Studios Focus Features · Geneon Universal (80.1%)[nu 1] · Illumination Entertainment • United International Pictures[nu 2] · Universal Animation Studios · Universal Pictures · PlayBack · Universal Studios Home Entertainment · Working Title Films Universal Parks & Resorts Universal Studios Dubailand · Universal Studios Hollywood · Universal Orlando Resort (Universal Studios Florida · Islands of Adventure · Universal CityWalk) · Universal Studios Japan · Universal Studios Singapore · Universal Studios South Korea Broadcast TV assets NBC · NBC News · NBC Sports · Telemundo NBCUniversal Cable A+E Networks (15%) · Bravo · Chiller · Cloo · CNBC · E! · G4 (88%) · MSNBC · Mun2 · Oxygen · PBS Kids Sprout (part owner)  · ShopNBC (30%) · Style Network  · Syfy · Telemundo Puerto Rico · Universal HD · USA Network · The Weather Channel[nu 3] · Weatherscan[nu 3] NBC Sports Group Golf Channel · NBC Sports Network · Universal Sports (part owner)[nu 4] · Alli Comcast SportsNet Bay Area (45%)  · California  · Chicago (20%)  · Houston  · Mid-Atlantic  · New England  · Northwest  · Philadelphia  · SNY (8%)  · The Mtn. (50%) · CSS (50%) · Comcast Sports Southwest  · New England Cable News  · Comcast Network CNBC CNBC global channels CNBC · CNBC Africa · CNBC Asia · CNBC Europe · CNBC Latin America · CNBC World CNBC Europe branches Class CNBC (20%) · CNBC Africa · CNBC Arabiya (according to CNBC Europe) · CNBC-e · CNBC Nordic · TVN CNBC CNBC Asia branches CNBC-TV18 · CNBC Australia · CNBC Awaaz · CNBC Hong Kong · CNBC Pakistan · CNBC Singapore · Nikkei CNBC · SBS-CNBC Universal Networks International 13th Street Universal · Diva Universal · KidsCo[nu 5] · Movies 24 · Steel[nu 6] · Studio Universal · Syfy · Universal Channel Syfy global channels Asia · Australia · Benelux · France · Germany · Japan · Latin America · Poland · Portugal · Romania · Russia · Serbia · Slovenia · Spain · UK · US NBCUniversal Television Group NBC Studios · NBCUniversal Television Distribution · Telemundo of Puerto Rico Studios · Telemundo Television Studios · Universal Television NBC O&Os California Nonstop · KNBC · KNSD[nu 7] · KNTV · KXAS[nu 7] (DFW Nonstop) · WCAU (NBC Philadelphia Nonstop)  · WMAQ (Chicago Nonstop) · WNBC (New York Nonstop) · WRC (Washington Nonstop) · WTVJ · WVIT Telemundo O&Os KBLR · KDEN · KEJT-LP · KHRR · KNSO[nu 8] · KSTS · KTAZ · KTMD · KVDA[nu 8] · KVEA · KXTX · WKAQ · WNEU[nu 8] · WNJU · WSCV · WSNS ShopNBC O&Os WWDP Internet ventures: Hulu[nu 9] · iVillage · msnbc.com[nu 10] · Television Without Pity · DailyCandy · Fandango Other assets: EMKA, Ltd. · qubo[nu 11] · WSI Corporation[nu 3]  · International Media Distribution Defunct properties: NBC Weather Plus (2004–2008) · Trio (1997–2005) · Diva TV (2007−2012) · Hallmark Channel International (1997−2011) · Discovery Kids (1996-2010) · Discovery Kids on NBC (2002-2006) · DreamWorks Records (1996-2005) · Go Fish Pictures (2000-2007) See also: Vivendi (former NBCUniversal stockholder and current parent company of Universal Music Group) · Comcast (telecommunications company that holds 51%) · General Electric (conglomerate that holds 49%) · MCA Inc. (legal predecessors of NBCUniversal) ^ Co-owned with Dentsu. ^ 50%, with Viacom's Paramount Pictures. ^ a b c Co-owned with Blackstone Group and Bain Capital. ^ minority share, InterMedia Partners is the majority owner. ^ Co-owned with Corus Entertainment and Cookie Jar Group. ^ Co-owned with Mediaset. ^ a b The stations are co-owned with LIN TV in a joint venture (76% owned by NBC, 24% owned by LIN). ^ a b c The stations are owned by NBCUniversal, but are controlled by ZGS Broadcast Holdings. ^ Co-owned with News Corporation and The Walt Disney Company. ^ Co-owned with Microsoft in a joint venture (50% owned by NBC, 50% owned by Microsoft). ^ Co-owned with Corus Entertainment, Classic Media, Nelvana, Scholastic Books and ION Media Networks.

Marc Faber, born February 28, 1946,^[1] is a Swiss investor.

Background[link]

Faber was born in Zürich and schooled in Geneva, Switzerland,^[1] where he raced for the Swiss National Ski Team. He studied Economics at the University of Zurich and, at the age of 24, obtained a Ph.D. degree in Economics magna cum laude.^[2] Faber is best known for the Gloom Boom & Doom Report newsletter and its related web site featuring "Dance of Death" paintings created by Kaspar Meglinger.^[3]

During the 1970s Faber worked for White Weld & Company Limited in New York City, Zürich, and Hong Kong. He moved to Hong Kong in 1973. He was a managing director at Drexel Burnham Lambert Ltd Hong Kong^[4] from the beginning of 1978 until the firm's collapse in 1990. In 1990, he set up his own business, Marc Faber Limited. Faber now resides in Chiangmai, Thailand, though he keeps a small office in Hong Kong.^[5]

Faber has a reputation for being a contrarian investor and has been called "Doctor Doom" for a number of years. He was the subject of a book written by Nury Vittachi in 1998 entitled Doctor Doom - Riding the Millennial Storm - Marc Faber's Path to Profit in the Financial Crisis.^[6][7] Faber has become a frequent speaker in various forums and makes numerous appearances on television around the world including various CNBC and Bloomberg outlets, as well as on internet venues like Jim Puplava's internet radio show.^[8] Dr. Faber's also engaged the Barron's Roundtable^[9] and the Manhattan Mises Circle, lecturing on "Mirror, Mirror on the Wall, When is the Next AIG to Fall?"^[10] Faber is said to be 8'0" tall^[11]

Marc Faber Ltd.[link]

Faber's company, Marc Faber Limited, acts as an investment advisor concentrating on value investments with tremendous upside often based on contrarian investment philosophies. Faber also invests and acts as a fund manager to private wealthy clients. Faber is a regular speaker on the investment circuit, often quoted in the financial press for his non-conformist viewpoint and alternative investment philosophies. His current tag-line is: 'buy a $100 US bond and frame it to teach your children about inflation by watching the US bond value diminish to almost nothing over the next 20 years'^{[citation needed]}

Faber is famous for advising his clients to get out of the stock market one week before the October 1987 crash.^[12][13] However Faber said that this prediction was "accidental".

He lost money shorting US stocks in 1999 although his call was later vindicated. He admits that market timing is very difficult. Nevertheless, his market advice since 2000 is quite accurate. Faber predicted the rise of oil, precious metals, other commodities, emerging markets, and especially China in his book Tomorrow's Gold: Asia's Age of Discovery. He also correctly predicted the slide of the U.S. dollar since 2002^[14] and the 5/06 and 2/07 mini-corrections.^{[citation needed]} He stated that there are few value investments available, except for farmland and real estate in some emerging markets like Russia, Paraguay, and Uruguay.^[9] He believed in early 2007 that a major market correction was "imminent." (Fox News, 2-2007); however, by 5/2007 he was saying that U.S. equities were moderately overvalued — less so than those of emerging markets.

In a June 2008 interview with Bloomberg, he goes over his bearish views on a wide spectrum of investments: stocks, real estate and commodities. He is extremely critical of the Fed's inflationary actions. However, his views for the short-run were almost entirely deflationary except for holding precious metals; Faber still views hyperinflation as a certainty within the next 10 years. He also correctly expressed temporary bullishness for the U.S. dollar in the middle of 2008 before it dramatically recovered and positive expectations for holding the Japanese yen.^[15] In December 2008, Faber said, "I think a recovery will not come in the next couple of years, maybe in five, ten years' time" ^[16] On March 9, 2009, Faber correctly predicted a U.S. stock market bottom but incorrectly stated that the rally would last only six months.^[17]

Writings[link]

Faber writes the monthly investment newsletter The Gloom Boom & Doom Report which is subject to charge. He has also authored several books.

Dr. Faber has been a regular contributor to several leading publications around the world in the past, among them Forbes^[18][19] and International Wealth which is a sister publication of the Financial Times.^[20] He has contributed regularly to several websites such as Financial Intelligence, Asian Bond Portal, Die Welt, Finanzen, Boerse, AME Info, Swiss Radio, Apple Hong Kong and Taiwan, Quamnet, Winners, Wealth and Oriental Daily. He has also written occasionally for the International Herald Tribune, Wall Street Journal, and Borsa e Finanza.^[20]

Faber has been long term bearish about the American economy for a number of years and continues to be so. He concluded his June 2008 newsletter with the following mock quote:

"The federal government is sending each of us a $600 rebate. If we spend that money at Wal-Mart, the money goes to China. If we spend it on gasoline it goes to the Arabs. If we buy a computer it will go to India. If we purchase fruit and vegetables it will go to Mexico, Honduras and Guatemala. If we purchase a good car it will go to Germany. If we purchase useless crap it will go to Taiwan and none of it will help the American economy. The only way to keep that money here at home is to spend it on prostitutes and beer, since these are the only products still produced in US. I've been doing my part."^[21]

Funds[link]

Marc Faber serves as director or advisor of a number of investment funds that focus on emerging and frontier markets, including Leopard Capital’s Leopard Cambodia Fund and Leopard Sri Lanka Fund.^[22]

References[link]

External links[link]

• Marc Faber interview on Bloomberg September 2007 before rate cut decision
• Faber's website
• Comprehensive Interview w/ Marc Faber (Bloomberg TV)
• Bloomberg interview
• Financial Sense News Hour Jim Puplava Ask the Experts
• Video of a wide ranging discussion of the US Dollar, credit crunch and emerging markets on CNBC Oct. 22, 2007
• interview with RTL Z 16-03-2010
• Video of a June 2008 Bloomberg News interview critical of Fed chairman and entitled: Marc Faber Says Oil, Stocks, Real Estate Are Overvalued
• Dr. Doom: Short Treasuries, Buy Hard Assets — 29 December 2008 interview
• The Marc Faber Blog

Marc Faber Newsletters of Note[link]

• Investment Hocus Pocus
• A Modern History of Investment Booms
• Marc Faber blog

This article has multiple issues. Please help improve it or discuss these issues on the talk page. This biography of a living person needs additional citations for verification. Tagged since July 2011. It relies on references to primary sources or sources affiliated with the subject, rather than references from independent authors and third-party publications. Tagged since July 2011. It is written like a résumé. Tagged since July 2011.

Kiran Mazumdar-Shaw
Born	(1953-03-23) March 23, 1953 (age 59) Bangalore, India
Residence	Bangalore, India
Education	Mount Carmel College, Bangalore University.
Occupation	Chairperson of Biocon
Net worth	US$900 million (2010)[1]
Religion	Hindu
Spouse	John Shaw

Kiran Mazumdar-Shaw (Kannada: ಕಿರಣ್ ಮಜುಮ್ದರ್ ಷ; born 23 March 1953) is an Indian entrepreneur. She is the Chairman & Managing Director of Biocon Limited a biotechnology company based in Bangalore (Bangaluru), India.

Profile[link]

Kiran Mazumdar-Shaw was born on March 23, 1953 in Bangalore, India

Mazumdar-Shaw completed her schooling from the city’s Bishop Cotton Girl’s High School (1968). She wanted to join medical school but instead took up biology and completed her BSc Zoology Honours course from Mount Carmel College, Bangalore University (1973). She later did her post-graduation in Malting and Brewing from Ballarat College, Melbourne University (1975).

She worked as a trainee brewer in Carlton and United Breweries, Melbourne and as a trainee maltster at Barrett Brothers and Burston, Australia. She also worked for some time as a technical consultant at Jupiter Breweries Limited, Calcutta and as a technical manager at Standard Maltings Corporation, Baroda between 1975 and 1977.^[2]

She started Biocon in 1978 and spearheaded its evolution from an industrial enzymes manufacturing company to a fully integrated bio-pharmaceutical company with a well-balanced business portfolio of products and a research focus on diabetes, oncology and auto-immune diseases. She also established two subsidiaries: Syngene (1994) to provide development support services for discovery research and Clinigene (2000) to cater to clinical development services.^[3][2]

Her pioneering work in the sector has earned her several awards, including the prestigious Padma Shri (1989) and the Padma Bhushan (2005) from the government of India. She was recently named among TIME magazine’s 100 most influential people in the world. She is on the Forbes list of the world’s 100 most powerful women and the Financial Times’ top 50 women in business list.^[2]. She is also a member of the board of governors of the prestigious Indian School of Business ^[4] and Indian Institute of Technology Hyderabad^[5]

Biocon[link]

In 1978 , she joined Biocon Biochemicals Limited, of Cork, Ireland as a Trainee Manager. In the same year she started Biocon in the garage of her rented house in Bangalore with a seed capital of Rs. 10,000.

Initially, she faced credibility challenges because of her youth, gender and her untested business model. Not only was funding a problem as no bank wanted to lend to her, but she also found it difficult to recruit people for her start-up. With single-minded determination she overcame these challenges only to be confronted with the technological challenges associated with trying to build a biotech business in a country facing infrastructural woes. Uninterrupted power, superior quality water, sterile labs, imported research equipment, and advanced scientific skills were not easily available in India during the time.

She is responsible for steering Biocon on a trajectory of growth and innovation over the years. Within a year of its inception, Biocon became the first Indian company to manufacture and export enzymes to USA and Europe. In 1989, Biocon became the first Indian biotech company to receive US funding for proprietary technologies. In 1990, she upgraded Biocon’s in-house research program, based on a proprietary solid substrate fermentation technology.

In the same year, she incorporated Biocon Biopharmaceuticals Private Limited to manufacture and market a select range of biotherapeutics in a joint venture with the Cuban Centre of Molecular Immunology.

In 2004, she decided to access the capital markets to develop Biocon’s pipeline of research programs. Biocon’s IPO was oversubscribed 32 times and its first day at the bourses closed with a market value of $1.11 billion, making Biocon only the second Indian company to cross the $1-billion mark on the first day of listing.^[2]

She entered into more than 2,200 high-value R&D licensing and other deals within the pharmaceuticals and bio-pharmaceutical space between 2005 and 2010 and helped Biocon expand its global footprint to emerging and developed markets through acquisitions, partnerships and in-licensing. Her belief that healthcare needs can only be met with affordable innovation has been the driving philosophy that has helped Biocon manufacture and market drugs cost-effectively.

In 2007-08, a leading US trade publication, Med Ad News, ranked Biocon as the 20th leading biotechnology companies in the world and the 7th largest biotech employer in the world. Biocon also received the 2009 BioSingapore Asia Pacific Biotechnology Award for Best Listed Company.^[2]

Today, thanks to her leadership, Biocon is building cutting-edge capabilities, global credibility and global scale in its manufacturing and marketing activities. It has Asia’s largest insulin and statin facilities also the largest perfusion-based antibody production facilities.

Philanthropic activities[link]

In 2004, she started the Biocon Foundation to conduct health, education, sanitation, and environmental programs to benefit of the economically weaker sections of society.

The Biocon Foundation's 7 ARY clinics are located where healthcare facilities are poor and they offer clinical care, generic medicines and basic tests for those who cannot afford them. Each of the clinics serves a population of 50,000 people living within a radius of 10 km.^[2] All the clinics organize regular general health checks in remote villages by bringing in physicians and doctors from network hospitals. Each year, the Foundation touches more than 300,000 lives through its holistic healthcare approach.

She helped establish a 1,400-bed cancer care center at the Narayana Health City campus at Boommasandra, Bangalore, along with Dr. Devi Shetty of Narayana Hrudayalaya in 2007.

She liked the innovation model and thinking that Dr. Prasad Kaipa brought to Biocon and funded multi-year research at Indian School of Business by creating Biocon Cell for Innovation Management ^[6] as part of Center for Leadership Innovation and Change.

Awards[link]

Mazumdar-Shaw is the recipient of several prestigious awards including the Nikkei Asia Prize (2009) for Regional Growth, Express Pharmaceutical Leadership Summit Award (2009) for Dynamic Entrepreneur, the Economic Times ‘Businesswoman of the Year’ (2004), the ‘Veuve Clicquot Initiative For Economic Development For Asia, Ernst & Young's Entrepreneur of the Year Award for Life Sciences & Healthcare (2002), ‘Technology Pioneer’ recognition by World Economic Forum and The Indian Chamber of Commerce Lifetime Achievement Award.^[2]

She has also received the Karnataka Rajyotsava Award (2002), the ‘Business Woman of the Year’ Award from the Indian Business Leadership Award committee, CNBC-TV18 (2006), the Indian Merchants' Chamber Diamond Jubilee Endowment Trust's‘Eminent Businessperson of the Year Award’(2006) and the ‘Corporate Leadership Award’ by the American India Foundation (2005).^[2]

She also received an honorary Doctorate of Science in 2004, from her alma mater, Ballarat University, in recognition of her contributions to biotechnology, apart from being awarded honorary doctorates from University of Abertay, Dundee, UK (2007), University of Glasgow, UK (2008) and Heriot-Watt University, Edinburgh, UK (2008).

References[link]